ROCHELLE REIN: Open Payments
NPI 1578903266 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 27 payments from 11 companies in 2025. Trend: 2023 $572 · 2024 $379 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $102 |
| PFIZER INC. | 5 | $91 |
| Alkermes, Inc. | 3 | $73 |
| Exact Sciences Corporation | 3 | $58 |
| Amgen Inc. | 3 | $50 |
| Abbott Laboratories | 2 | $35 |
| ABBVIE INC. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: CAPLYTA, PREVNAR 20, VIVITROL, The Cologuard Plus Collection Kit, OTEZLA, FREESTYLE LIBRE 3, VRAYLAR, Auvelity.
Industry payments across MI — which companies pay providers there.
